Global Competition Review Names Maggie Segall to 2020 “40 Under 40” List

On August 26, 2019, Pitney Bowes Inc., a global technology company that provides commerce solutions in the areas of e‑commerce, shipping, mailing, data, and financial services, announced that it has entered into a definitive agreement to sell its Software Solutions business to Syncsort for $700 million in cash. Cravath is representing Pitney Bowes in connection with the transaction.

On August 22, 2019, Hasbro, Inc. and Entertainment One Ltd. (“eOne”) announced they have entered into a definitive agreement for Hasbro to acquire eOne in an all‑cash transaction valued at approximately $4 billion. Hasbro will add eOne’s family brands, proven TV and film expertise and veteran executive leadership. Cravath, along with Stikeman Elliot and Freshfields Bruckhaus Deringer, is representing Hasbro in connection with the transaction.

On July 29, 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, which is structured as an all-stock, Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. Pfizer shareholders would own 57% of the combined new company, and Mylan shareholders would own 43%. Cravath is representing Mylan in connection with the transaction.

On July 3, 2019, Synthomer plc (“Synthomer”), a United Kingdom-based specialty chemical company, announced that it has entered into a definitive agreement to acquire OMNOVA Solutions Inc. (“OMNOVA”), a global manufacturer of emulsion polymers, specialty chemicals and surfaces, for $10.15 per share in cash, which implies an enterprise value of $824 million. Cravath, alongside Herbert Smith Freehills, is representing Synthomer in connection with the transaction.